Improved Performance in Mammalian Cell Perfusion Cultures by Growth Inhibition

Biotechnology Journal
Moritz K F WolfMassimo Morbidelli

Abstract

Mammalian cell perfusion cultures represent a promising alternative to the current fed-batch technology for the production of various biopharmaceuticals. Long-term operation at a fixed viable cell density (VCD) requires a viable culture and a constant removal of excessive cells. Product loss in the cell removing bleed stream deteriorates the process yield. In this study, the authors investigate the use of chemical and environmental growth inhibition on culture performance by either adding valeric acid (VA) to the production media or by reducing the culture temperature (33.0 °C) with respect to control conditions (36.5 °C, no VA). Low temperature significantly reduces cellular growth, thus, resulting in lower bleed rates accompanied by a reduced product loss of 11% compared to 26% under control conditions. Additionally, the cell specific productivity of the target protein improves and maintained stable leading to media savings per mass of product. VA shows initially an inhibitory effect on cellular growth. However, cells seemed to adapt to the presence of the inhibitor resulting in a recovery of the cellular growth. Cell cycle and Western blot analyses support the observed results. This work underlines the role of temperature as...Continue Reading

References

Nov 3, 1989·Science·A B Pardee
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Jul 9, 1999·Biotechnology and Bioengineering·H KaufmannJ E Bailey
Dec 18, 2001·Biotechnology and Bioengineering·Shikiko WatanabeMohamed Al-Rubeai
Oct 20, 2005·Journal of Bioscience and Bioengineering·C LiuS Hwang
Sep 23, 2006·Advances in Biochemical Engineering/biotechnology·Konstantin KonstantinovDavid Naveh
Apr 17, 2007·PLoS Computational Biology·Matteo BarberisLilia Alberghina
Jul 19, 2008·Biotechnology and Bioengineering·M FusseneggerJ E Bailey
Jul 31, 2010·Biotechnology and Bioengineering·Neelanjan SenguptaJohn A Morgan
Jan 2, 2014·Molecular Biotechnology·William C YangYao-Ming Huang
Nov 25, 2014·Journal of Pharmaceutical Sciences·Konstantin B Konstantinov, Charles L Cooney
Feb 20, 2015·Biotechnology and Bioengineering·Matthew S CroughanCharles Cooney
May 28, 2015·Journal of Biotechnology·Jason WaltherKonstantin Konstantinov
Jun 16, 2015·Journal of Biotechnology·Rahul GodawatVeena Warikoo
Aug 9, 2016·Biotechnology and Bioengineering·Daniel J KarstMassimo Morbidelli
Mar 1, 2015·Journal of Pharmaceutical Sciences·Konstantin B Konstantinov, Charles L Cooney

❮ Previous
Next ❯

Citations

Apr 6, 2019·Biotechnology and Bioengineering·Matthew GagnonGregory W Hiller
Jan 11, 2020·Frontiers in Bioengineering and Biotechnology·Nagesh K Tripathi, Ambuj Shrivastava
Feb 8, 2019·Biotechnology Journal·Suzanne S Farid
Jan 5, 2021·Current Opinion in Chemical Engineering·Sofie A O'Brien, Wei-Shou Hu
Sep 21, 2021·Biotechnology Progress·Markus SchulzeDirk E Martens
Dec 1, 2021·Critical Reviews in Biotechnology·Michael A MacDonaldTrent Munro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.